| Abivax Sa | — | 391.8K | $52.8M | 9.1% | — | Held |
| Scholar Rock Hldg Corp | — | 886.9K | $39.1M | 6.7% | — | Held |
| Centessa Pharmaceuticals Plc | — | 1.15M | $28.9M | 4.9% | — | Held |
| Syndax Pharmaceuticals Inc | SNDX | 1.34M | $28.1M | 4.8% | — | Held |
| Structure Therapeutics Inc. | GPCR | 351.1K | $24.4M | 4.2% | — | Held |
| Arcellx Inc | — | 332.9K | $21.7M | 3.7% | — | Held |
| Roivant Sciences Ltd. | ROIV | 966.7K | $21M | 3.6% | — | Held |
| Terns Pharmaceuticals Inc | — | 429.2K | $17.3M | 3.0% | — | Held |
| Twist Bioscience Corp | TWST | 518.4K | $16.4M | 2.8% | — | Held |
| Immunovant, Inc. | IMVT | 645K | $16.4M | 2.8% | — | Held |
| Dyne Therapeutics, Inc. | DYN | 835.2K | $16.3M | 2.8% | — | Held |
| Xenon Pharmaceuticals Inc. | XENE | 348.6K | $15.6M | 2.7% | — | Held |
| Surrozen Inc | — | 619.8K | $12.7M | 2.2% | — | Held |
| Celcuity Inc. | CELC | 118.3K | $11.8M | 2.0% | — | Held |
| Mineralys Therapeutics, Inc. | MLYS | 290K | $10.5M | 1.8% | — | Held |
| Madrigal Pharmaceuticals, Inc. | MDGL | 17.7K | $10.3M | 1.8% | — | Held |
| Adaptive Biotechnologies Cor | — | 606.8K | $9.85M | 1.7% | — | Held |
| Palisade Bio, Inc. | PALI | 4.19M | $9.85M | 1.7% | — | Held |
| Cytokinetics Inc | CYTK | 147K | $9.34M | 1.6% | — | Held |
| Edgewise Therapeutics, Inc. | EWTX | 360.9K | $8.96M | 1.5% | — | Held |
| Bright Minds Biosciences Inc. | DRUG | 97.3K | $7.6M | 1.3% | — | Held |
| Nektar Therapeutics | NKTR | 178.3K | $7.54M | 1.3% | — | Held |
| Johnson & Johnson | JNJ | 35K | $7.24M | 1.2% | — | Held |
| Denali Therapeutics Inc. | DNLI | 419.1K | $6.92M | 1.2% | — | Held |
| Amylyx Pharmaceuticals, Inc. | AMLX | 565.1K | $6.83M | 1.2% | — | Held |
| ClearPoint Neuro, Inc. | CLPT | 481.9K | $6.59M | 1.1% | — | Held |
| Arcutis Biotherapeutics, Inc. | ARQT | 224.7K | $6.53M | 1.1% | — | Held |
| EyePoint, Inc. | EYPT | 353.8K | $6.46M | 1.1% | — | Held |
| Immatics N.V. | IMTX | 610.3K | $6.41M | 1.1% | — | Held |
| Ocular Therapeutix, Inc | OCUL | 522.7K | $6.35M | 1.1% | — | Held |
| Rhythm Pharmaceuticals, Inc. | RYTM | 58.9K | $6.31M | 1.1% | — | Held |
| Praxis Precision Medicines I | — | 21.1K | $6.21M | 1.1% | — | Held |
| Apogee Therapeutics, Inc. | APGE | 80.6K | $6.08M | 1.0% | — | Held |
| Incyte Corp | INCY | 61.4K | $6.07M | 1.0% | — | Held |
| IDEAYA Biosciences, Inc. | IDYA | 161.7K | $5.59M | 1.0% | — | Held |
| Assembly Biosciences, Inc. | ASMB | 156.7K | $5.33M | 0.9% | — | Held |
| Maze Therapeutics, Inc. | MAZE | 125.9K | $5.22M | 0.9% | — | Held |
| Protagonist Therapeutics, Inc | PTGX | 59.4K | $5.19M | 0.9% | — | Held |
| Eli Lilly & Co | LLY | 4.76K | $5.11M | 0.9% | — | Held |
| Trevi Therapeutics, Inc. | TRVI | 399.6K | $5M | 0.9% | — | Held |
| Revolution Medicines Inc | — | 62K | $4.94M | 0.8% | — | Held |
| Viridian Therapeutics Inc | — | 154.3K | $4.8M | 0.8% | — | Held |
| Arbutus Biopharma Corp | ABUS | 986.8K | $4.75M | 0.8% | — | Held |
| Moonlake Immunotherapeutics | MLTX | 348.4K | $4.59M | 0.8% | — | Held |
| CytomX Therapeutics, Inc. | CTMX | 1.04M | $4.41M | 0.8% | — | Held |
| X4 Pharmaceuticals, Inc | XFOR | 898.5K | $3.59M | 0.6% | — | Held |
| Whitehawk Therapeutics, Inc. | WHWK | 1.46M | $3.53M | 0.6% | — | Held |
| Dianthus Therapeutics Inc | — | 79.3K | $3.27M | 0.6% | — | Held |
| Ascendis Pharma A/S | ASND | 14.8K | $3.16M | 0.5% | — | Held |
| Repligen Corp | RGEN | 15.7K | $2.57M | 0.4% | — | Held |
| Newamsterdam Pharma Company | — | 73.1K | $2.56M | 0.4% | — | Held |
| MBX Biosciences, Inc. | MBX | 78.6K | $2.48M | 0.4% | — | Held |
| Quince Therapeutics, Inc. | QNCX | 739.3K | $2.48M | 0.4% | — | Held |
| Avalo Therapeutics, Inc. | AVTX | 135.6K | $2.46M | 0.4% | — | Held |
| Invivyd, Inc. | IVVD | 989.8K | $2.44M | 0.4% | — | Held |
| Meiragtx Hldgs Plc | — | 287.7K | $2.29M | 0.4% | — | Held |
| Inventiva Sa | — | 467.2K | $2.17M | 0.4% | — | Held |
| AbbVie Inc. | ABBV | 9.32K | $2.13M | 0.4% | — | Held |
| Adc Therapeutics Sa | ADCT | 502.6K | $1.77M | 0.3% | — | Held |
| MapLight Therapeutics, Inc. | MPLT | 100K | $1.76M | 0.3% | — | Held |
| Pharvaris N.V. | PHVS | 58.4K | $1.62M | 0.3% | — | Held |
| Legend Biotech Corp | LEGN | 73.3K | $1.59M | 0.3% | — | Held |
| Belite Bio, Inc | BLTE | 9.16K | $1.47M | 0.3% | — | Held |
| Xilio Therapeutics, Inc. | XLO | 2.03M | $1.3M | 0.2% | — | Held |
| Evommune, Inc. | EVMN | 68.2K | $1.17M | 0.2% | — | Held |
| Bridgebio Oncology Therapeut | — | 86.5K | $1.08M | 0.2% | — | Held |
| Spyre Therapeutics, Inc. | SYRE | 32.4K | $1.06M | 0.2% | — | Held |
| Uniqure Nv | — | 43.5K | $1.04M | 0.2% | — | Held |
| Taysha Gene Therapies, Inc. | TSHA | 182.1K | $1M | 0.2% | — | Held |
| Monte Rosa Therapeutics, Inc. | GLUE | 61.6K | $965.5K | 0.2% | — | Held |
| Sab Biotherapeutics Inc | — | 146.6K | $548.1K | 0.1% | — | Held |
| Vanda Pharmaceuticals Inc. | VNDA | 59K | $520.3K | 0.1% | — | Held |
| Capricor Therapeutics, Inc. | CAPR | 17.9K | $515.2K | 0.1% | — | Held |
| Pasithea Therapeutics Corp | — | 355.1K | $458.1K | 0.1% | — | Held |
| Vistagen Therapeutics, Inc. | VTGN | 616.7K | $142.1K | 0.0% | — | Held |